|Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial|
CC Iwuji, J Orne-Gliemann, J Larmarange, E Balestre, R Thiebaut, ...
The lancet HIV 5 (3), e116-e125, 2018
|Uptake of home-based HIV testing, linkage to care, and community attitudes about ART in rural KwaZulu-Natal, South Africa: descriptive results from the first phase of the ANRS …|
CC Iwuji, J Orne-Gliemann, J Larmarange, N Okesola, F Tanser, ...
PLoS medicine 13 (8), e1002107, 2016
|Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial …|
CC Iwuji, J Orne-Gliemann, F Tanser, S Boyer, RJ Lessells, F Lert, J Imrie, ...
Trials 14 (1), 1-15, 2013
|Access to primary healthcare during lockdown measures for COVID-19 in rural South Africa: an interrupted time series analysis|
MJ Siedner, JD Kraemer, MJ Meyer, G Harling, T Mngomezulu, P Gabela, ...
BMJ open 10 (10), e043763, 2020
|Access to HIV care in the context of universal test and treat: challenges within the ANRS 12249 TasP cluster‐randomized trial in rural South Africa|
M Plazy, KE Farouki, C Iwuji, N Okesola, J Orne‐Gliemann, J Larmarange, ...
Journal of the International AIDS Society 19 (1), 20913, 2016
|What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?|
D Havlir, S Lockman, H Ayles, J Larmarange, G Chamie, T Gaolathe, ...
Journal of the International AIDS Society 23 (2), e25455, 2020
|Older HIV-infected individuals present late and have a higher mortality: Brighton, UK cohort study|
CC Iwuji, D Churchill, Y Gilleece, HA Weiss, M Fisher
BMC public health 13 (1), 1-9, 2013
|The impact of universal test and treat on HIV incidence in a rural South African population: ANRS 12249 TasP trial, 2012–2016|
C Iwuji, J Orne-Gliemann, E Balestre, J Larmarange, R Thiebaut, F Tanser, ...
AIDS Conference, 18-22, 2016
|Linkage to HIV care after home‐based HIV counselling and testing in sub‐Saharan Africa: a systematic review|
E Ruzagira, K Baisley, A Kamali, S Biraro, H Grosskurth, ...
Tropical medicine & international health 22 (7), 807-821, 2017
|Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the …|
S Boyer, C Iwuji, A Gosset, C Protopopescu, N Okesola, M Plazy, B Spire, ...
AIDS care 28 (sup3), 39-51, 2016
|Impact of chromosomal instability on colorectal cancer progression and outcome|
B Orsetti, J Selves, C Bascoul-Mollevi, L Lasorsa, K Gordien, F Bibeau, ...
BMC cancer 14 (1), 1-13, 2014
|Reduction in early mortality on antiretroviral therapy for adults in rural South Africa since change in CD4+ cell count eligibility criteria|
RJ Lessells, PC Mutevedzi, CC Iwuji, ML Newell
Journal of acquired immune deficiency syndromes (1999) 65 (1), e17, 2014
|Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal|
J Orne-Gliemann, J Larmarange, S Boyer, C Iwuji, N McGrath, ...
BMC public health 15 (1), 1-14, 2015
|Impact of next-generation sequencing defined human immunodeficiency virus pretreatment drug resistance on virological outcomes in the ANRS 12249 treatment-as-prevention trial|
A Derache, CC Iwuji, K Baisley, S Danaviah, AG Marcelin, V Calvez, ...
Clinical Infectious Diseases 69 (2), 207-214, 2019
|“It is better to die”: experiences of traditional health practitioners within the HIV treatment as prevention trial communities in rural South Africa (ANRS 12249 TasP trial)|
M Moshabela, T Zuma, J Orne-Gliemann, C Iwuji, J Larmarange, ...
Aids Care 28 (sup3), 24-32, 2016
|Antiretroviral therapy to prevent HIV acquisition in serodiscordant couples in a hyperendemic community in rural South Africa|
CE Oldenburg, T Bärnighausen, F Tanser, CC Iwuji, V De Gruttola, ...
Reviews of Infectious Diseases 63 (4), 548-554, 2016
|Virological outcomes of second-line protease inhibitor–based treatment for human immunodeficiency virus type 1 in a high-prevalence rural South African setting: a competing …|
D Collier, C Iwuji, A Derache, T de Oliveira, N Okesola, A Calmy, F Dabis, ...
Clinical infectious diseases 64 (8), 1006-1016, 2017
|Universal test and treat is not associated with sub‐optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial|
C Iwuji, N McGrath, A Calmy, F Dabis, D Pillay, ML Newell, K Baisley, ...
Journal of the International AIDS Society 21 (6), e25112, 2018
|The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu‐Natal (South Africa)|
J Larmarange, MH Diallo, N McGrath, C Iwuji, M Plazy, R Thiébaut, ...
Journal of the International AIDS Society 21, e25128, 2018
|Community perceptions of repeat HIV-testing: experiences of the ANRS 12249 Treatment as Prevention trial in rural South Africa|
J Orne-Gliemann, T Zuma, J Chikovore, N Gillespie, M Grant, C Iwuji, ...
Aids Care 28 (sup3), 14-23, 2016